Bharat Parenterals Limited
BSE: BPLPHARMA
Prev Close
1167.4
Open Price
1170.1
Volume
2,012
Today Low / High
1170.1 / 1202.8
52 WK Low / High
802 / 1590
Range
1,130 - 1,249
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1189.7, reflecting a change of 22.3 (1.91023%). The expected target range on the BSE is 1,130 - 1,249. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Bharat Parenterals Limited Graph
Bharat Parenterals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bharat Parenterals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,189.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,189.70 | 1,201.60 | 1,081.44 - 1,321.76 |
| 1,213.49 | 970.80 - 1,456.19 | ||
| 1,225.39 | 857.77 - 1,593.01 | ||
| Bearish Scenario | 1,189.70 | 1,177.80 | 1,060.02 - 1,295.58 |
| 1,165.91 | 932.72 - 1,399.09 | ||
| 1,154.01 | 807.81 - 1,500.21 |
Overview of Bharat Parenterals Limited
ISIN
INE365Y01019
Industry
Medical - Pharmaceuticals
Vol.Avg
1,933
Market Cap
7,753,455,000
Last Dividend
1
Official Website
IPO Date
DCF Diff
3,499.38
DCF
-1,745
Financial Ratios Every Investor Needs
Stock Dividend of BPLPHARMA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-06-25 | June 25, 24 | 1 | 1 | 2024-06-25 | 2024-08-01 | |
| 2023-09-25 | September 25, 23 | 0.75 | 0.75 | 2023-09-25 | 2023-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 340.38 Cr | 185.48 Cr | 154.90 Cr | 0.4551 | 0.00 Cr | 0.00 Cr | -32.62 Cr | -12.63 Cr | 0.00 | 14.32 Cr | -0.0371 |
| 2024-03-31 | 257.05 Cr | 168.24 Cr | 88.80 Cr | 0.3455 | 1.03 Cr | 6.13 Cr | 17.18 Cr | 14.52 Cr | 24.94 | 26.57 Cr | 0.0565 |
| 2023-03-31 | 217.98 Cr | 174.96 Cr | 43.02 Cr | 0.1974 | 1.05 Cr | 41.88 Cr | 15.34 Cr | 16.44 Cr | 28.47 | 31.93 Cr | 0.0754 |
| 2022-03-31 | 212.01 Cr | 168.43 Cr | 43.58 Cr | 0.2056 | 1.42 Cr | 18.72 Cr | 22.78 Cr | 21.05 Cr | 36.67 | 29.33 Cr | 0.0993 |
| 2021-03-31 | 204.64 Cr | 164.32 Cr | 40.32 Cr | 0.1970 | 1.71 Cr | 17.93 Cr | 20.02 Cr | 20.39 Cr | 35.59 | 33.80 Cr | 0.0996 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.56 Cr | 648.53 Cr | 309.53 Cr | 330.6700 Cr | 180.20 Cr | 179.64 Cr | 71.95 Cr | 229.10 Cr | 0.00 Cr | 0.00 Cr | 1.52 Cr | 219.3000 Cr |
| 2024-03-31 | 8.71 Cr | 503.82 Cr | 265.65 Cr | 197.2668 Cr | 157.58 Cr | 148.87 Cr | 61.47 Cr | 233.37 Cr | 0.00 Cr | 0.00 Cr | 2.42 Cr | 190.3838 Cr |
| 2023-03-31 | 8.91 Cr | 351.37 Cr | 133.47 Cr | 182.7963 Cr | 49.74 Cr | 40.83 Cr | 41.08 Cr | 160.86 Cr | 7.46 Cr | 0.00 Cr | 3.53 Cr | 119.7982 Cr |
| 2022-03-31 | 4.66 Cr | 226.88 Cr | 56.74 Cr | 165.8250 Cr | 17.75 Cr | 13.08 Cr | 23.08 Cr | 76.65 Cr | 2.11 Cr | 0.00 Cr | 3.42 Cr | 41.5309 Cr |
| 2021-03-31 | 2.42 Cr | 198.94 Cr | 55.12 Cr | 143.8658 Cr | 12.24 Cr | 9.82 Cr | 23.72 Cr | 45.07 Cr | 1.18 Cr | 0.00 Cr | 4.73 Cr | 43.6255 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -27.2500 Cr | -137.1100 Cr | 156.0900 Cr | -56.3300 Cr | -8.2700 Cr | 0.4400 Cr | -29.0800 Cr | -33.9500 Cr | 22.6100 Cr | -0.5800 Cr | -10.4800 Cr |
| 2024-03-31 | -4.7057 Cr | -104.7840 Cr | 110.4276 Cr | -109.0078 Cr | 0.9380 Cr | 8.7791 Cr | -104.3021 Cr | 14.5171 Cr | 107.8356 Cr | -0.4331 Cr | -23.6255 Cr |
| 2023-03-31 | 20.7745 Cr | -48.3311 Cr | 31.9989 Cr | -70.8262 Cr | 4.2474 Cr | 8.9108 Cr | -91.6007 Cr | 16.4404 Cr | -1.2438 Cr | 0.0000 Cr | -17.0818 Cr |
| 2022-03-31 | -1.6335 Cr | -2.5956 Cr | 5.9512 Cr | -40.5857 Cr | 2.2476 Cr | 4.6634 Cr | -38.9522 Cr | 21.0528 Cr | 1.1789 Cr | 0.0000 Cr | 1.6723 Cr |
| 2021-03-31 | 30.6132 Cr | -48.1096 Cr | 9.0704 Cr | 24.7517 Cr | -7.9703 Cr | 2.4158 Cr | -5.8615 Cr | 20.3892 Cr | 9.7473 Cr | 0.0000 Cr | 6.3830 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 103.98 Cr | 53.54 Cr | 50.44 Cr | 0.4851 | -6.29 Cr | -4.72 Cr | 0.00 | 4.16 Cr | -0.0454 |
| 2024-12-31 | 72.26 Cr | 35.67 Cr | 36.59 Cr | 0.5064 | -5.11 Cr | -1.68 Cr | -2.44 | 6.59 Cr | -0.0232 |
| 2024-09-30 | 71.63 Cr | 61.33 Cr | 10.30 Cr | 0.1438 | -16.68 Cr | -7.51 Cr | -11.51 | -3.46 Cr | -0.1048 |
| 2024-06-30 | 92.51 Cr | 54.57 Cr | 37.94 Cr | 0.4101 | 28.02 Cr | 1.28 Cr | 2.20 | -2.28 Cr | 0.0138 |
| 2024-03-31 | 67.82 Cr | 54.56 Cr | 13.26 Cr | 0.1955 | -2.88 Cr | -0.30 Cr | -0.52 | 3.63 Cr | -0.0044 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.56 Cr | 5.42 Cr | 67.99 Cr | 171.84 Cr | 71.95 Cr | 355.51 Cr | 229.10 Cr | 648.53 Cr | 309.53 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 39.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -304.02 Cr |
| 2024-09-30 | 8.81 Cr | 35.29 Cr | 44.10 Cr | 159.24 Cr | 39.54 Cr | 278.63 Cr | 228.14 Cr | 541.83 Cr | 237.81 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 10.88 Cr | 0.00 Cr | 0.00 Cr | 10.88 Cr | 0.00 Cr | 0.00 Cr | -238.17 Cr |
| 2024-03-31 | 8.71 Cr | 2.17 Cr | 10.88 Cr | 145.55 Cr | 61.47 Cr | 259.91 Cr | 233.37 Cr | 503.82 Cr | 265.65 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -4.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -1.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -7.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.30 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹890.05 | ₹106,533,493,392.00 | ₹85,406.00 |
Key Executives
Gender: male
Year Born:
Gender: female
Year Born:
Gender: male
Year Born: 1964
Gender: female
Year Born:
Gender: female
Year Born:
Gender: male
Year Born: 1968
FAQs about Bharat Parenterals Limited
The CEO is Mr. Bharatkumar Rameshchandra Desai.
The current price is ₹1,125.00.
The range is ₹802-1590.
The market capitalization is ₹775.35 crores.
The dividend yield is 0.09%.
The P/E ratio is -57.11.
The company operates in the Healthcare sector.
Overview of Bharat Parenterals Limited (ISIN: INE365Y01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹775.35 crores and an average daily volume of 1,933 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.